title: Totally implantable vascular access devices in cystic fibrosis: a four-year experience with fifty-eight patients.
authors.affiliation: Department of Surgery, Rainbow Babies and Childrens Hospital, Cleveland, OH 44106.
authors.forename: J B
authors.initials: JB
authors.lastname: Morris
authors.forename: M E
authors.initials: ME
authors.lastname: Occhionero
authors.forename: M W
authors.initials: MW
authors.lastname: Gauderer
authors.forename: R C
authors.initials: RC
authors.lastname: Stern
authors.forename: C F
authors.initials: CF
authors.lastname: Doershuk
mesh_terms: D000293:Adolescent; D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001424:Bacterial Infections; D002405:Catheterization, Central Venous / Q000295:instrumentation; D002406:Catheterization, Peripheral / Q000295:instrumentation; D002408:Catheters, Indwelling / Q000009:adverse effects; D002648:Child; D003550:Cystic Fibrosis / Q000188:drug therapy*; D004867:Equipment Design; D005260:Female; D006801:Humans; D008297:Male; D009339:Needles; D012826:Silicone Elastomers; D013350:Subclavian Vein; D013927:Thrombosis / Q000209:etiology; D013997:Time Factors
chemical_list: D000900:Anti-Bacterial Agents; D012826:Silicone Elastomers